Clinical Study

IBS symptoms reduced with UAS multi-species probiotic blend

Format: PDF file | Document type: Clinical Study

IBS symptoms reduced with UAS multi-species probiotic blend

UAS Probiotic Blend 003 is a multi-species probiotic blend recently used in a clinical study of IBS patients. The probiotic blend contains the superstrain, Lactobacillus acidophilus DDS-1, Bifidobacterium longum UABL-14, Bifidobacterium bifidum UABB 10, Bifidobacterium lactis UABLA 12 and FOS at a potency of 12 billion CFU/g. It was used to treat IBS patients for 8 weeks.

Physicians looked for at least a 50% reduction in the six most common symptoms of IBS. At the end of 8 weeks, between 72% and 92% of patients were experiencing positive results in one or more symptoms. This probiotic blend is available from UAS Laboratories, Inc. Eden Prairie, MN 55344 USA (www.uaslabs.com). www.uaslabs.com.

Latest content from UAS Laboratories

show more

Related resources from UAS Laboratories

Show more

Supplier info centre